Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis

Medical Mycology

Volumn 48, Issue 5, 2010, Pages 696-703

  Badali, H ^a,b,c   Bonifaz, A ^d   Barrn Tapia, T ^e   Vzquez Gonzlez, D ^d   Estrada Aguilar, L ^e   Cavalcante Oliveira, N M ^f   Sobral Filho, J F ^g   Guarro, J ^h   Meis, J F G M ⁱ   De Hoog, G S ^a,b,j  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d General Hospital   (Mexico)

^e Dermatology Service   (Mexico)

^f Laboratório de Micologia Departamento de Ciências Farmacêuticas   (Mexico)

^g FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^h UNIVERSITAT ROVIRA I VIRGILI   (Spain)

ⁱ CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^j PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

more..

Author keywords

Black yeasts; Chromoblastomycosis; ITS rDNA; Rhinocladiella aquaspersa; Rhinocladiella phaeophora

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CASPOFUNGIN; CORTICOSTEROID; ECHINOCANDIN; FLUCONAZOLE; ISAVUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; TERBINAFINE; TRIAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; TRIAZOLE DERIVATIVE;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BRAZIL; CASE REPORT; CHROMOMYCOSIS; EXUDATE; FEMALE; FUNGUS; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; RHINOCLADIELLA AQUASPERSA; ASCOMYCETES; BIOPSY; CHROMOBLASTOMYCOSIS; CYTOCHEMISTRY; CYTOLOGY; DRUG EFFECTS; FOREARM; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; SKIN;

CHAETOTHYRIALES; FUNGI; RHINOCLADIELLA AQUASPERSA; RHINOCLADIELLA PHAEOPHORA;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASCOMYCOTA; BIOPSY; BRAZIL; CHROMOBLASTOMYCOSIS; CYTOLOGICAL TECHNIQUES; ECHINOCANDINS; FEMALE; FOREARM; HISTOCYTOCHEMISTRY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SKIN; TRIAZOLES;

EID: 77954784902     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903471073     Document Type: Article

References (39)

1. Queiroz-Telles F, Esterre P, Perez-Blanco M, et al. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol 2009; 47: 3-15.
2. Badali H, Carvalho VO, Vicente V, et al. Cladophialophora saturnica sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol 2009; 47: 51-62.
3. Badali H, Gueidan C, Najafzadeh MJ, et al. Biodiversity of the genus Cladophialophora. Stud Mycol 2008; 61: 175-191.
4. Badali H, Najafzadeh MJ, Van Esbroeck M, et al. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species. Med Mycol 2009; 29: 1-10.
5. Queiroz-Telles F, McGinnis MR, Salkin I, et al. Subcutaneous mycoses. Infect Dis Clin North Am 2003; 17: 59-85.
6. Padhye AA, Ajello L. A case of chromoblastomycosis with special reference to the mycology of the isolated Exophiala jeanselmei. Mykosen 1987; 30: 134.
7. Piepenbring M, Cańceres Mendez OA, Espino Espinoza A, et al. Chromoblastomycosis caused by Chaetomium funicola: a case report from Western Panama. Brit J Derm 2007; 157: 1025-1029.
8. Crous PW, Braun U, Groenewald JZ. Mycosphaerella is polyphyletic. Stud Mycol 2007; 58: 1-32.
9. Campolina SS, Caligiorne RB, Rezende-Silva S, et al. A skin infection mimicking chromoblastomycosis by a Capnodialean fungus. Med Mycol [E-pub Ahead of print 29 july 2009. DOI 10.1080/13693780903148353] 2009; 47: 81-85.
10. Carrí AL. Chromoblastomycosis. Ann N Y Acad Sci 1950; 50: 1255-1282.
11. Ogawa MM, Alchorne MM, Barbieri A, et al. Lymphoscintigraphic analysis in chromoblastomycosis. Int J Dermatol 2003; 42: 622-625.
12. Takase T, Baba T, Uyeno K. Chromomycosis. A case with a widespread rash, lymph node metastasis and multiple subcutaneous nodules. Mycoses 1988; 31: 343-352.
13. Muhammed K, Nandakumar G, Asokan KK, Vimi P. Lymphangitic chromoblastomycosis. Indian J Dermatol Venereol Leprol 2006; 72: 443-445.
14. Borelli D. Acrotheca aquaspersa nova sp., agente de cromomicosis. Acta Cient Venez 1972; 23: 193-196.
15. Arango M, Jaramillo C, Cortes A, Restrepo A. Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa. Med Mycol 1998; 36: 43-45.
16. Marques S G, Pedrozo Silva CM, Resende MA, et al. Chromoblastomycosis caused by Rhinocladiella aquaspersa. Med Mycol 2004; 42: 261-265.
17. Sutton D A, Slifkin M, Yakulis R, Rinaldi MG. U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J Clin Microbiol 1998; 36: 708-715.
18. Campbell CL, Al-Hedaithy SS. Phaeohyphomycosis of the brain caused by Ramichloridiwn mackenziei sp. nov. in Middle Eastern countries. J Med Vet Mycol 1993; 31: 325-332.
19. Gams W, Verkley GJM, Crous PW. CBS Course of Mycology, 5th edn. Utrecht, The Netherlands: Centraalbureau voor Schimmelcultures, 2007.
20. De Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi, 2nd edn. Utrecht/Reus: Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, 2000.
21. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A2; 2nd edn: CLSI, Wayne, PA, USA, 2008.
22. Arzanlou M, Groenewald JZ, Gams W, et al. Phylogenetic and morphotaxonomic revision of Ramichloridium and allied genera. Stud Mycol 2007; 58: 57-93
23. Schell WA, McGinnis MR, Borelli D. Rhinocladiella aquaspersa a new combination for Acrotheca aquaspersa. Mycotaxon 1983; 17: 341-348.
24. Jae BJ, Park YJ, Kim DW, Suh SB. Chromoblastomycosis caused by Rhinocladiella aquaspersa. Kor J Med Mycol 2004; 9: 117-122.
25. Pires dAvila SCG, Pagliari C, Duarte MIS. The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathologia 2002; 156: 51-60.
26. Corbellini VA, Scroferneker ML, Carissimi M, Santolin LD. Delayedtype hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoi CMMI 1 grown in different culture media. Mycopathologia 2006; 162: 51-55.
27. Iwatsu T, Miyaji M, Taguchi H, Okamoto S. Evaluation of skin test for chromoblastomycosis using antigens prepared from culture filtrates of Fonsecaea pedrosoi, Phialophora verrucosa, Wangiella dermatitidis and Exophiala jeanselmei. Mycopathologia 1982; 77: 59-64.
28. Ahrens J, Graybill JR, Abishawl A, et al. Experimental murine chromomycosis mimicking chronic progressive human disease. Am J Trop Med Hyg 1989; 40: 651-658.
29. Esterre P, Queiroz-Telles F. Managements of chromoblastomycosis: novel perspectives. Curr Opin Infect Dis 2006; 19: 148-152.
30. Cardona-Castro N, Agudelo-Flïez P. Development of a chronic chromoblastomycosis model in immunocompetent mice. Med Mycol 1999; 37: 81-83.
31. De Hoog GS, Nishikaku AS, Ferńdez Zeppenfeldt G, et al. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud Mycol 2007; 58: 219-234.
32. Harutyunyan S, Muggia L Grube M. Black fungi in lichens from seasonally arid habitats. Stud Mycol 2008; 61: 83-90.
33. Bonifaz A. Paredes-Sol V, Sa A. Treating chromoblastomycosis with systemic antifungals. Exp Opin Pharmacother 2004; 5: 247-254.
34. Bonifaz A, Saul A, Paredes-Solis V, Araiza J, Fierro-Arias L. Treatment of chromoblastomycosis with terbinafine: experience with four cases. J Dermatol Treat 2005; 16: 47-51.
35. Vanden Bossche H, Dromer F, Improvisi I, et al. Antifungal drug resistance in pathogenic fungi. Med Mycol 1998; 38: 119-128.
36. Gonzalez GM, Fothergill AW, Sutton DA, et al. In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi. Med Mycol 2005; 43: 281-284.
37. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, et al. Head-to-head comparison of the activities of currently available antifungal agents against 3378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006; 50: 917-921.
38. Odabasi Z, Paetznick VL, RodriguezJR, et al. In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrob Agents Chemother 2004; 48: 1912-1915.
39. Badali H, De Hoog GS, Curfs-Breuker I, et al. In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species. J Antimicrob Chemother 2009; 63: 1295-1297.